Pharmacy
Hello, Suzanne Dixon
Manage E-mail  |  Logout

Article ID

Home
General Pharmacy
Messages (38)
Conferences
Jobs
Newsletters
My Library
Topics in
Pharmacy
        Adverse Drug Reactions
        Antimicrobials
        Basic Science
        Cardiac/Hypertension
        Chemotherapy/Oncology
        Complementary Medicine
        Dosing
        Drug Approvals
        Drug Interactions
        Drug Resistance
        Drug Trials
        Drug/Product Alerts
        Economics of Medicine
        Major Studies
        Neuro/Psych pharmacology
        Other Drugs
        Over The Counter (OTC)
        Pain Management
        Patient Counseling
        Pharmacoeconomics
        Pharmacokinetics
        Pharmacy Management
        Popular Press
        Stomach/GI
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor

Messages

Need hemophilia CME? Here’s the latest, straight from ISTH 2009 in Boston, with expert commentary on the topics you...
Victoria Luken, MDLinx CME
FDA Update: Anti-CD20 Antibody Granted Accelerated Approval for CLL
Tracy Hampton, PhD, MDLinx Oncology
RACs In Full Gear
Roberta Buell, MBA, Sausalito Healthcare Partners
  See all

Articles: Drug Approvals



Latest (2) Month's Top Read  
Receive free subspecialty "5-minute updates" via email

Prior Articles


Teva Announces Approval And Launch Of Generic Urso 250 And Urso Forte
Teva Pharmaceutical Industries, 05/15/09    Free full text
Sponsor
Genentech to Present Advances With Targeted Cancer Medicines at ASCO
Genentech, 05/15/09    Free full text
Medtronic Demonstrates Positive Results on First Pacemaker Designed for Use with MRI
Medtronic, 05/15/09    Free full text
Novartis receives approval from FDA to market Prevacid 24HR as first and only OTC proton pump inhibitor in original prescription formulation
Novartis, 05/15/09    Free full text
UCB"s Cimzia Approved in the U.S. for Adult Patients Suffering from Moderate to Severe Rheumatoid Arthritis -- Enzon to receive royalties for PEGylation technology--
Enzon Pharmaceuticals, 05/15/09    Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/14/09    Free full text
FDA Approves ACTOplus met XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
Takeda Pharmaceuticals North America, 05/14/09
Boston Scientific Announces European Approval and First Implants of New Defibrillation Lead System Designed to Simplify the Surgical Process
Boston Scientific, 05/13/09    Free full text
Medtronic to Seek Indication Expansion for Heart Failure Device Therapy
Medtronic, 05/13/09    Free full text
Corporate Governance
Patheon, 05/13/09
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/12/09    Free full text
FDA Approves Drug for Treatment of Aggressive Brain Cancer
FDA Press Releases, 05/11/09    Free full text
Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 05/11/09    Free full text
FDA Approves Pancreatic Enzyme Replacement Product for Marketing in United States
FDA Press Releases, 05/08/09    Free full text
Glivec approved in EU as first post-surgery therapy to reduce risk of cancer returning in patients with aggressive gastrointestinal tumors
Novartis, 05/08/09    Free full text
Mylan Receives Final FDA Approvals for Generic Versions of Anti-Rejection Medication CellCept
Mylan, 05/08/09
Important New Treatment Option Approved in US for Patients with the Most Aggressive Form of Brain Cancer
Roche, 05/07/09    Free full text
FDA Approves New Influenza Vaccine Production Facility
FDA Press Releases, 05/07/09    Free full text
Medtronic Completes Early Enrollment in U.S. Study of Endurant Abdominal Aortic Stent Graft
Medtronic, 05/07/09    Free full text
FDA Approves New Medtronic Left Heart Lead for Cardiac Resynchronization Therapy Devices
Medtronic, 05/07/09    Free full text

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more...
166 Available Pages
First    Prev    15      16      17      18      19      20      21      22      23      24      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Pharmacy Articles Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.